Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial (Q86584617)
Jump to navigation
Jump to search
scientific article published on 01 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial |
scientific article published on 01 February 2015 |
Statements
Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial (English)
Maximilian von Eynatten
Markku Laakso
Julio Rosenstock
Per-Henrik Groop
Anthony H Barnett
Baptist Gallwitz
Uwe Hehnke
Ilkka Tamminen
Sanjay Patel
Hans-Juergen Woerle
1 February 2015